Objective To compare gemcitabine-irinotecan (IRINOGEM) combination chemotherapy with gemcitabine (GEM) alone in patients with advanced pancreatic cancer (APCa) through meta-analysis.

• 目的通过Meta分析,探讨吉西他滨联合伊立替康治疗晚期胰腺癌的地位和价值。